BACILLUS EXPRESSION SYSTEM
    4.
    发明申请

    公开(公告)号:US20250043293A1

    公开(公告)日:2025-02-06

    申请号:US17311675

    申请日:2019-12-06

    Abstract: An inducible promoter expression system based on the T7 RNA Polymerase (T7 RNAP), lactose repressor (Lad), and a chimeric T7lac promoter (PT7lac), which can be integrated as a single copy into the B. subtilis genome. In the absence of IPTG. Lad strongly represses T7RNAP and PT7lac, and expression of an exemplary ORF—here superfolder green fluorescent protein (sfGFP) reporter protein—is undetectable by flow cytometry. Addition of IPTG de-represses PT7lac, and simultaneously induces expression of T7RNAP, resulting in very high sfGFP levels.

    METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING HUMAN GUT MICROBES

    公开(公告)号:US20250034579A1

    公开(公告)日:2025-01-30

    申请号:US18716858

    申请日:2022-12-06

    Abstract: Dysbiosis has been linked to diseases such as inflammatory bowel disease and obesity. Multi-omics studies have uncovered significant associations between microbiota genes and diseases. Many of these genes are exclusively expressed in non-model microbes such as Firmicutes/Clostridia. A pipeline for building microbial genetic manipulation systems would be a first step to manipulating these genes in vivo and causally connecting them with host diseases. The present technology relates generally to compositions and the methods of preparations thereof for genetically engineering gut-microbiota in vitro. The present technology further relates to uses of compositions in vivo.

Patent Agency Ranking